Veracyte Inc (VCYT)
22.88
-0.52
(-2.22%)
USD |
NASDAQ |
May 17, 16:00
22.88
0.00 (0.00%)
After-Hours: 20:00
Veracyte Cash from Operations (Quarterly): -8.966M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -8.966M |
| December 31, 2023 | 15.55M |
| September 30, 2023 | 14.17M |
| June 30, 2023 | 16.67M |
| March 31, 2023 | -2.172M |
| December 31, 2022 | 9.744M |
| September 30, 2022 | 7.026M |
| June 30, 2022 | -0.363M |
| March 31, 2022 | -8.872M |
| December 31, 2021 | 8.446M |
| September 30, 2021 | -1.393M |
| June 30, 2021 | 1.887M |
| March 31, 2021 | -40.56M |
| December 31, 2020 | 2.261M |
| September 30, 2020 | 1.752M |
| June 30, 2020 | -8.423M |
| March 31, 2020 | -5.301M |
| December 31, 2019 | 1.79M |
| September 30, 2019 | -1.556M |
| June 30, 2019 | -2.455M |
| March 31, 2019 | -1.011M |
| December 31, 2018 | -1.226M |
| September 30, 2018 | -1.783M |
| Date | Value |
|---|---|
| June 30, 2018 | -3.099M |
| March 31, 2018 | -7.413M |
| December 31, 2017 | -5.816M |
| September 30, 2017 | -5.103M |
| June 30, 2017 | -4.91M |
| March 31, 2017 | -8.086M |
| December 31, 2016 | -4.232M |
| September 30, 2016 | -7.438M |
| June 30, 2016 | -7.714M |
| March 31, 2016 | -8.598M |
| December 31, 2015 | -2.83M |
| September 30, 2015 | -3.802M |
| June 30, 2015 | -11.47M |
| March 31, 2015 | -8.867M |
| December 31, 2014 | -8.436M |
| September 30, 2014 | -6.532M |
| June 30, 2014 | -5.907M |
| March 31, 2014 | -6.757M |
| December 31, 2013 | -3.298M |
| September 30, 2013 | -5.238M |
| June 30, 2013 | -4.004M |
| March 31, 2013 | -6.619M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-40.56M
Minimum
Mar 2021
16.67M
Maximum
Jun 2023
-0.0381M
Average
0.6945M
Median
Cash from Operations (Quarterly) Benchmarks
| Fonar Corp | 2.807M |
| XWELL Inc | -3.201M |
| ProPhase Labs Inc | -5.119M |
| Applied DNA Sciences Inc | -3.21M |
| OncoCyte Corp | -3.83M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 2.878M |
| Cash from Financing (Quarterly) | -0.864M |
| Free Cash Flow | 26.33M |
| Free Cash Flow Per Share (Quarterly) | -0.1485 |
| Free Cash Flow to Equity (Quarterly) | -11.10M |
| Free Cash Flow to Firm (Quarterly) | -11.10M |
| Free Cash Flow Yield | 1.57% |